Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes
- PMID: 6174877
- DOI: 10.1016/0197-4580(81)90032-4
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes
Abstract
Activities relating to 3 neurotransmitter and 4 neuropeptide systems have been examined in human temporal lobe (post mortem) for their relationships with age and Alzheimer-type changes (senile plaques and cognitive function). Significant alterations with increasing age (from 61 to 92 years) in a series of non-demented cases included a reduction of the cholinergic enzyme, choline acetyltransferase, and an increase in vasoactive intestinal peptide immunoreactivity. In cases of alzheimer's disease the only neurochemical activity investigated which correlated significantly with cognitive impairment (assessed from a Mental Test Score obtained shortly before death) and with the severity of Alzheimer-type abnormalities (senile plaques density) was choline acetyltransferase. Further analyses of the data in relation to the severity of plaque formation suggest that alterations in other neurochemical activities including reductions in dopamine-beta-hydroxylase activity, cholecystokinin octapeptide (aqueous extracted) and somatostatin immunoreactivities and an increase in substance P immunoreactivity, may occur at later stages of the disease process. These comparative data suggest that biochemical changes in this brain area associated with age and earlier stages of Alzheimer's disease may be relatively selective.
Similar articles
-
Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.Exp Brain Res. 1982;Suppl 5:140-5. doi: 10.1007/978-3-642-68507-1_19. Exp Brain Res. 1982. PMID: 6185355 No abstract available.
-
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.Br Med J. 1978 Nov 25;2(6150):1457-9. doi: 10.1136/bmj.2.6150.1457. Br Med J. 1978. PMID: 719462 Free PMC article.
-
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.J Neurol Sci. 1981 Aug;51(2):279-87. doi: 10.1016/0022-510x(81)90106-4. J Neurol Sci. 1981. PMID: 7276979
-
Neuropeptides in Alzheimer's disease: a review and morphological results.Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):271-86. doi: 10.1016/0278-5846(86)90007-2. Prog Neuropsychopharmacol Biol Psychiatry. 1986. PMID: 2432629 Review.
-
Senile dementia and presenile dementia.Tohoku J Exp Med. 1990 Aug;161 Suppl:49-60. doi: 10.1620/tjem.161.supplement_49. Tohoku J Exp Med. 1990. PMID: 1707190 Review.
Cited by
-
Physical Exercise and Alzheimer's Disease: Effects on Pathophysiological Molecular Pathways of the Disease.Int J Mol Sci. 2021 Mar 12;22(6):2897. doi: 10.3390/ijms22062897. Int J Mol Sci. 2021. PMID: 33809300 Free PMC article. Review.
-
Secretion of growth hormone and thyroid-stimulating hormone in patients with dementia.Clin Investig. 1994 Jul;72(7):489-93. doi: 10.1007/BF00207475. Clin Investig. 1994. PMID: 7981574 Clinical Trial.
-
Monoamine neurons in aging and Alzheimer's disease.J Neural Transm Gen Sect. 1993;91(2-3):135-59. doi: 10.1007/BF01245229. J Neural Transm Gen Sect. 1993. PMID: 8099796 Review.
-
Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear.J Neurosci. 1996 May 1;16(9):3089-96. doi: 10.1523/JNEUROSCI.16-09-03089.1996. J Neurosci. 1996. PMID: 8622138 Free PMC article.
-
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.J Neurochem. 2021 Sep;158(6):1394-1411. doi: 10.1111/jnc.15471. Epub 2021 Aug 6. J Neurochem. 2021. PMID: 34272732 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical